BLB&B Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,083
Closed -$206K 298
2018
Q3
$206K Buy
+1,083
New +$199K 0.03% 282
2016
Q1
Sell
-814
Closed -$254K 279
2015
Q4
$254K Hold
814
0.05% 223
2015
Q3
$221K Hold
814
0.05% 253
2015
Q2
$247K Hold
814
0.05% 235
2015
Q1
$242K Buy
+814
New +$232K 0.05% 237

Other funds holding AGN

BLB&B Advisors's AGN Position: Q4 2018 in Review

BLB&B Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,083 shares — an estimated $206K sold.

BLB&B Advisors first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $254K in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • BLB&B Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • BLB&B Advisors sold 1,083 Allergan plc shares in Q4 2018, an estimated $206K.
  • BLB&B Advisors first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • BLB&B Advisors's Allergan plc position peaked at $254K in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on BLB&B Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.